CVI Investments, Inc. - Sep 30, 2025 SCHEDULE 13G/A Report for Galmed Pharmaceuticals Ltd. Ordinary Shares, NIS 1.80 par value per share (GLMD)

Filing Manager: CVI Investments, Inc.
Reporting Manager: CVI Investments, Inc.
Security: Galmed Pharmaceuticals Ltd. Ordinary Shares, NIS 1.80 par value per share
Symbol: GLMD
Shares outstanding: 5.59M shares
Disclosed Ownership: 173K shares
Ownership: 3.1%
Form type: SCHEDULE 13G/A
Date filed: 11/7/2025, 04:51 PM
Date of event: Sep 30, 2025
Previous filing: Aug 14, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
CVI Investments, Inc.	3.1%	173K	0	173K	/s/ Sarah Travis	Sarah Travis, Assistant General Counsel and Assistant Secretary of Heights Capital Management, Inc.
Heights Capital Management, Inc.	3.1%	173K	0	173K	/s/ Sarah Travis	Sarah Travis, Assistant General Counsel and Assistant Secretary